DrugPatentWatch Database Preview
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Profile
When do Quinapril Hydrochloride And Hydrochlorothiazide patents expire, and when can generic versions of Quinapril Hydrochloride And Hydrochlorothiazide launch?
Quinapril Hydrochloride And Hydrochlorothiazide is a drug marketed by Apotex Corp, Aurobindo Pharma, Invagen Pharms, Mylan, and Sun Pharm Inds Ltd. and is included in five NDAs.
The generic ingredient in QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.
Summary for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Suppliers / Packagers: | 6 |
| Clinical Trials: | 7 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
Pharmacology for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| Ingredient-type | Thiazides |
| Drug Class | Thiazide Diuretic Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Increased Diuresis |
